Study of Abiraterone Acetate Plus Prednisone in Patients With Chemo-naive Metastatic Castration-Resistant Prostate Cancer
Clinical trial NCT01591122 · COMPLETED
Trial details
- NCT number
- NCT01591122
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-27
- Primary completion
- 2016-12-31
- Enrollment
- 313
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.